Kyle Bransfield

Kyle Bransfield is an experienced finance professional who currently serves as the Chairman and Chief Executive Officer of APx Acquisition Corp. I (Nasdaq: APXI).13 He was appointed to these roles on February 6, 2024, replacing Daniel Braatz.1

Professional Experience

Bransfield is the founder and CEO of Union Acquisition Group, where he has been leading SPAC (Special Purpose Acquisition Company) and investment activities since November 2017.2 His career spans over 15 years in public markets investing, SPAC management, private equity, and investment banking.4

Some of his notable positions include:

• Independent Director at Moolec Science (Nasdaq: MLEC) since December 20222
• Independent Director at Procaps Group (NASDAQ: PROC) since September 202124
• Co-Founder, CEO, and Director of Union Acquisition Corp. II (Nasdaq: LATN) from October 2019 to September 20212
• Independent Director at Bioceres Crop Solutions (NYSE: BIOX) from March 2019 to November 20222

Education and Qualifications

Bransfield holds a degree in Finance and Economics from American University's Kogod School of Business.24 He also possesses Series 79 and Series 63 licenses.2

Expertise

His expertise lies in:

• SPAC management and investments
• Direct equity and debt private markets principal investing
• Capital raising
• Investment banking

Kyle Bransfield's extensive experience in finance and his track record in managing SPACs make him well-suited for his current role at APx Acquisition Corp. I, where he is responsible for guiding the company's strategic direction and operations.34